MicroRNAs as biomarkers for CNS cancer and other disorders

Enrico De Smaele, Elisabetta Ferretti, Alberto Gulino

Research output: Contribution to journalArticlepeer-review


The use of miRNAs as biomarkers has gained growing interest in the last few years. Their role in regulating a great variety of targets and, as a consequence, multiple pathways, makes their use in diagnostics a powerful tool to be exploited for early detection of disease, risk assessment and prognosis and for the design of innovative therapeutic strategies. While still not fully validated, profiling of blood cells, exosomes or body fluid miRNAs would represent a tremendous and promising advance in non-invasive diagnostics of CNS disorders. A major challenge is represented by technological aspects of miRNA detection and discovery aiming to genome-wide high throughput, sensitive and accurate analysis. Although there is much to be learned in the field, this review will highlight the potential role of miRNA as a new class of biomarkers in several CNS disorders, including neurodegenerative diseases such as Alzheimer, Huntington and Parkinson diseases, schizophrenia and autism as well as different types of cancer (e.g. gliomas and medulloblastomas).

Original languageEnglish
Pages (from-to)100-111
Number of pages12
JournalBrain Research
Publication statusPublished - Jun 18 2010


  • Glioma
  • Medulloblastoma
  • miRNA
  • Neurodegeneration
  • Tumors

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology


Dive into the research topics of 'MicroRNAs as biomarkers for CNS cancer and other disorders'. Together they form a unique fingerprint.

Cite this